FDA and EMA Accept Regulatory Submission for Pfizer ’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
Filings based on clinical data demonstrating significant scalp hair regrowth versus placebo
NEW YORK--(BUSINESS WIRE) September 09, 2022 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) accepted for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 9, 2022 Category: Drugs & Pharmacology Source Type: news
Future Is Brighter for Alopecia Treatment: Expert
For many people with severe alopecia areata, who have lived with baldness, or with scalps only sparsely dotted with hair, or with missing eyebrows or lashes, the future has a new look. (Source: WebMD Health)
Source: WebMD Health - July 19, 2022 Category: Consumer Health News Source Type: news
Baricitinib for Alopecia Areata: Starting Patients on Treatment Baricitinib for Alopecia Areata: Starting Patients on Treatment
Physicians should be ready for questions on who should get the drug, how fast it works, and what patients should consider regarding the label ' s boxed warning.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 2, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Picture of Alopecia Areata (Nails)
Title: Picture of Alopecia Areata (Nails)Category: ImagesCreated: 10/19/2009 12:46:00 PMLast Editorial Review: 6/28/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - June 28, 2022 Category: Dermatology Source Type: news
FDA Approves First Pill to Treat Severe Alopecia Areata
TUESDAY, June 14, 2022 -- The first pill to treat adults with severe alopecia areata was approved by the U.S. Food and Drug Administration on Monday.
Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the entire body... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2022 Category: Pharmaceuticals Source Type: news
F.D.A. Approves Alopecia Drug That Restores Hair Growth in Many Patients
The drug, made by Eli Lilly, is already used for rheumatoid arthritis, and could be followed by two more drugs from other companies. (Source: NYT Health)
Source: NYT Health - June 13, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: your-feed-science Alopecia Areata Eli Lilly and Company Food and Drug Administration Source Type: news
FDA approves alopecia areata treatment with roots at Yale
In a Q&A, Brett King discusses the FDA ’s announcement of the drug baricitinib as the first-ever approved treatment for the autoimmune disorder alopecia areata. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 13, 2022 Category: Universities & Medical Training Source Type: news
FDA OKs First Systemic Treatment for Alopecia Areata FDA OKs First Systemic Treatment for Alopecia Areata
Baricitinib, a JAK inhibitor, is now approved for the treatment of adults with severe AA. The disease affects more than 300,000 people in the US every year.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 13, 2022 Category: Allergy & Immunology Tags: Dermatology News Alert Source Type: news
FDA Approves First Systemic Treatment for Alopecia Areata
(MedPage Today) -- The FDA approved the Janus kinase (JAK) inhibitor baricitinib (Olumiant) as the first systemic treatment for alopecia areata.
The approval pertains to adults with severe alopecia areata, which affects more than 300,000 people... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 13, 2022 Category: American Health Source Type: news
FDA approves first systemic treatment for alopecia areata
Today, the U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300,000 people in the U.S. each year. Today's action marks the first FDA approval of a systemic treatment (i.e. treats the entire body rather than a specific location) for alopecia areata. (Source: World Pharma News)
Source: World Pharma News - June 13, 2022 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
FDA Approves Lilly and Incyte's Olumiant (baricitinib) as First and Only Systemic Medicine for Adults with Severe Alopecia Areata
INDIANAPOLIS, June 13, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved Olumiant (baricitinib), a once-daily pill, as a first-in-disease... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 13, 2022 Category: Drugs & Pharmacology Source Type: news
What causes alopecia, a 'devastating' hair loss condition affecting Jada Pinkett Smith
Alopecia areata is the condition affecting Jada Pinkett Smith, who found herself at the center of the Will Smith-Chris Rock conflict at the Oscars ceremony March 27. Dr. Brett King answers FAQs about the causes, severity, challenges, treatments and more. (Source: CNN.com - Health)
Source: CNN.com - Health - June 1, 2022 Category: Consumer Health News Source Type: news
Pinkett Smith talks hair-loss 'shame,' outcome of Oscar slap - The Associated Press
LOS ANGELES — Jada Pinkett Smith turned her husband's Oscar-night blowup into a teachable moment about alopecia areata, the hair-loss disorder affecting her and millions of others that, in some... #jadapinkettsmith #hairloss #theassociatedpress (Source: Reuters: Health)
Source: Reuters: Health - June 1, 2022 Category: Consumer Health News Source Type: news
Arthritis treatment which can help patients with alopecia
One baricitinib success story is Tracy Watkins, 53, from North London, who has been taking it daily since her diagnosis of alopecia areata in May 2019. (Source: the Mail online | Health)
Source: the Mail online | Health - May 28, 2022 Category: Consumer Health News Source Type: news
Alopecia drug regrows hair in 40% of patients with condition suffered by Jada Pinkett-Smith
A Yale University, Connecticut, study of the twice-a-day pill found four in 10 patients with alopecia areata were able to regrow nearly a full head of hair within half a year. (Source: the Mail online | Health)
Source: the Mail online | Health - May 25, 2022 Category: Consumer Health News Source Type: news
